Letter to Congress Opposing Legislation That Would Expand Promotion of Medical Products for Unapproved Uses

June 5, 2017

View as PDF.

Read press release.

Public Citizen and 12 other groups sent a letter to members of U.S. House of Representatives’ Energy and Commerce Committee urging them to oppose two bills that would significantly expand marketing for unapproved uses of drugs and medical devices that have been approved or cleared by the FDA for at least one use. The legislation would undermine regulatory standards for ensuring that drugs and medical devices are safe and effective for each marketed use.

See Public Citizen’s other work on off-label use.